Probiota Americas 2026 in pictures
From regulation and women’s health to healthy aging and commercialization, this year’s conference brought together the people and ideas shaping the next chapter of microbiome innovation.
Regulation & policy
Understanding the complex frameworks moving the companion animal market forward
The companion animal supplement industry in North America operates on intricate frameworks that are changing quickly as regulatory environments shift.
Monster targets gray-market energy drink imports in ITC investigation
The U.S. International Trade Commission (USITC) has initiated an investigation into alleged gray-market imports of Monster Energy Company products following a complaint that certain imported energy drinks and their labeling infringe several of the...
Airborne lawsuit tests front-of-pack dosage claims
The case highlights how consumer perception can lead to false advertising allegations, even when labels comply with FDA requirements.
Growing demand for evidence-backed fiber drives Myota’s $4.5m funding round
Patented prebiotic fiber blend Myota has raised $4.5 million in a Series A round led by venture capital firm PeakBridge to expand its clinically validated prebiotic fibre business.
UNPA to sunset at the end of 2026 with Israelsen’s retirement
After 34 years of industry leadership and advocacy, the United Natural Products Alliance (UNPA) will conclude operations at the end of 2026, following the retirement of its founder and president, Loren Israelsen.
What can 25 years of data reveal about supplement use?
Consumers are increasingly taking supplements and more than two decades of consumption may explain how trends have evolved.
NPA engages Texas AG’s office amid ongoing protein powder probe
The Natural Products Association (NPA) met with representatives of the Texas attorney general’s office last week to discuss the state’s industry-wide investigation into protein powder manufacturers.
Function acquires SuppCo to connect supplement recommendations with health data
Function, a health platform that provides lab testing, imaging and personalized health insights, has acquired SuppCo, a supplement intelligence platform focused on helping consumers evaluate supplement quality and trustworthiness.
FDA warning letter surrounding herpes products underscores potential misuse of AI
A U.S. Food and Drug Administration warning letter issued earlier this year is continuing to spur conversation about the appropriate use of AI to comply with the agency’s regulations.
Guest article
Why a ‘Day on the Hill’ still matters
On June 10, executives from across the dietary supplement and functional food industry will gather in Washington, D.C., for CRN’s annual Day on the Hill. We will spend the day meeting with Members of Congress and their staff to discuss policies that...
Across the Nutraverse: H&B in APAC, Garcinia in France, FTC vs Amare
Catch up with our weekly round-up of key news from across the Nutraverse.
‘Unmatched’: Nutra Healthspan Summit returns for November 2026
Described by one attendee as “an event with wall-to-wall speakers who delivered insightful, topical, useable information”, the Nutra Healthspan Summit is returning to London for its 2nd edition with more high-level content and networking opportunities.
Probiota Americas 2026: Market dynamics, regulations, microbiome mitigation of environmental pollutants, and companion animals headline Day 1
Probiota Americas is less than two weeks away with must-see speakers on Day 1 including Nick Gibson (Nielsen IQ), Peter McMath (WPIC), Dr. Stan Kubow (McGill University), Dr Martha Cline (Nestlé Purina Petcare), Dr. Anna Lindell (Cambiotics), and more!
Senate bill would let HSAs & FSAs cover dietary supplements
Senators Kevin Cramer (R-ND) and John Curtis (R-UT) have introduced the Dietary Supplements Access Act to amend the Internal Revenue Code to recognize dietary supplements as qualified medical expenses eligible for reimbursement through Health Savings...
Moringa recalls spotlight pathogen risks across botanical supply chains
The FDA investigation, which closed April 1, tied recalled moringa supplements to more than 100 illnesses, drawing renewed industry attention to testing, traceability and supplier verification practices.
FDA investigator outlines issues with gummy manufacturing
Supplement gummy production is known for being challenging as companies must consider everything from sugar content to foreign material exposure.
News in brief
Indian high court grants interim stay on ashwagandha leaf ban
The Karnataka High Court in Bangalore has temporarily stayed the Indian government’s restriction on the use of ashwagandha leaves issued last month after industry stakeholders challenged the rationale behind the blanket ban.
NutraCast: How Military Energy Gum became the first NSF Certified for Sport gum product
What started as a military solution for fatigue has evolved into one of the more unexpected formats in performance nutrition: Military Energy Gum (MEG). The chewable delivery system was originally developed for warfighters and has become the first gum...
NAD decision on magnesium gummies raises questions around compound weight claims
The ruling adds to broader industry discussion about how mineral forms and elemental nutrient amounts are communicated to consumers.
FDA Shakeup: Makary steps down, Diamantas steps up
The leadership transition at the U.S. Food and Drug Administration adds uncertainty for industries navigating shifting enforcement and public health priorities.
Behind the scenes tour: From ingredients to the shelf
A recent tour through several facilities in Tempe, Arizona, offered a behind-the-scenes look at the dietary supplement industry. From raw ingredient sourcing and testing to formulation, manufacturing and finished products, what ultimately reaches store...
NutraCast: How Nutrify C-Suite SumFlex is redefining industry events
As India’s nutraceutical sector continues to accelerate onto the global stage, the upcoming Nutrify C-Suite SumFlex Summit in Mumbai is positioning itself less as a traditional conference and more as a high-level working boardroom for industry leaders.
FDA flags eBay listing over GLP-1 claims in rare warning letter
The U.S. Food and Drug Administration (FDA) rarely goes after eBay sellers, which is exactly why it caught Asa Waldstein’s eye.
National Advertising Division refers Iron Rock NAD+ claims to regulators as participation dynamics come into focus
The BBB National Programs’ National Advertising Division (NAD) has referred Iron Rock Ventures LLC to regulatory authorities after the company did not confirm whether it would comply with recommendations to modify or discontinue certain advertising...
FDA’s largest infant formula test yet finds ‘low’ contaminants – but no new rules
FDA’s infant formula test found mostly trace contaminants, but without standards, enforcement or pre‑market testing, the data leaves critical questions unanswered
Across the Nutraverse: India’s ashwagandha leaf ban, prebiotics in Canada, sports nutrition opportunity
Catch up with our weekly round-up of key news from across the Nutraverse.
Rep. Langworthy continues push for Dietary Supplement Regulatory Uniformity Act
The bill aims to clarify federal preemption so that supplements meeting FDA requirements are not subjected to a patchwork of laws at the state level.
Health Canada publishes prebiotics monograph
Health Canada’s Natural and Non-prescription Health Products Directorate (NNHPD) has published a monograph for prebiotics, establishing a clear set of rules and the basis for health claims in Canada.
Across the Nutraverse: Clinical trials for active women, Andrographis in Australia, MPL in the House
Catch up with our weekly round-up of key news from across the Nutraverse.
FTC order in TruHeight case signals scrutiny of height claims and incentivized reviews
The Federal Trade Commission’s (FTC) action against TruHeight is providing the dietary supplement industry with a detailed look at how the agency is approaching claim substantiation, youth-targeted marketing and consumer review practices, combining...
Dietary Supplement Listing Bill introduced in the House
A first-term member of Congress has introduced the Dietary Supplement Listing Act of 2026 in the U.S. House of Representatives to require dietary supplement manufacturers to list their products with the Food and Drug Administration (FDA).
‘Not as bad as the media says’: Future Nutra Foundation pushes transparency via new testing initiative
Transparency is taking center stage in the supplement industry and the Future Nutra Foundation is launching an effort to independently test products off the shelf and make those results publicly accessible.
NAD flags Bayer One A Day men’s fertility positioning
The National Advertising Division (NAD) has recommended that Bayer HealthCare LLC discontinue or modify a series of claims tied to its One A Day Men’s Pre-Conception Health Complete Multivitamin, concluding that product positioning and messaging conveyed...
A growing problem: Lead testing uncovers ‘deeply concerning issue’ in spirulina supply chain
Global demand for spirulina is booming, with the market for this superfood projected to reach $1.3 billion by 2032. But new testing revealed some cracks in quality and safety that suggest some top-selling products may expose consumers to elevated lead...
SANS 2026: State-level rules and class action trends raise new stakes for supplement brands
Dietary supplement companies may be focused on FDA activity in Washington, but at the Sports & Active Nutrition Summit (SANS), Rend Al‑Mondhiry, partner at Amin Wasserman Gurnani LLP, warned that some of the major risks are emerging much closer to home.